KRRO
Korro Bio, Inc.
Korro Bio, Inc. (KRRO) has 11 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 17, 2026.
The most active filer is Director FORMELA JEAN FRANCOIS with 5 filings. Insiders have net sold $4.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Ram Aiyar
- Employees:49
- HQ:Cambridge, MA, US
- IPO:2019-10-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.4M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$191.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 100,700 | $1.4M | Jul 7 | SEC ↗ | |
| Director | Sale | 9,323 | $130K | Jul 7 | SEC ↗ | |
FORMELA JEAN FRANCOISFirst filing | Director | Sale | 3,962 | $55K | Jun 25 | SEC ↗ |
FORMELA JEAN FRANCOISFirst filing | Director | Sale | 119,005 | $1.7M | Jun 25 | SEC ↗ |
FORMELA JEAN FRANCOISFirst filing | Director | Sale | 48,438 | $707K | Jun 25 | SEC ↗ |
Chappell ToddFirst filing | Chief Operating Officer | Sale | 3,168 | $34K | Jun 17 | SEC ↗ |
Dolan OliverFirst filing | Senior Vice President, Finance | Sale | 3,383 | $37K | Jun 17 | SEC ↗ |
Vincent Loic AFirst filing | Chief Scientific Officer | Sale | 3,418 | $37K | Jun 17 | SEC ↗ |
Cerio JeffreyFirst filing | General Counsel | Sale | 6,609 | $72K | Jun 17 | SEC ↗ |
Aiyar RamFirst filing | President and CEO | Sale | 15,152 | $197K | Jun 2 | SEC ↗ |
Related companies
Korro Bio, Inc. is in the Healthcare sector.